Italy’s New Law on Gender Transition Healthcare for Minors

The Italian government has introduced a draft law aimed at tightening control over gender transition healthcare for minors. This law was approved by the Cabinet on Monday but still requires parliamentary approval. Officials argue that its implementation is crucial for enhancing “effective data surveillance” to safeguard the health of young people.

This legislation focuses on regulating the use of puberty blockers and hormones for individuals under 18 who are experiencing gender dysphoria. Notably, the bill will require protocols from the Ministry of Health, which are not yet established, and will need to be reviewed by the National Ethics Committee of Pediatricians before moving forward.

Additionally, the law proposes the establishment of a national registry managed by the Italian pharmaceutical agency, which intends to track proper administration of these treatments while collecting medical histories of transgender individuals receiving support.

The bill has faced opposition and protests from advocates for trans rights.

Prime Minister Giorgia Meloni has positioned herself against what she calls the LGBTQ+ lobby and “gender ideology,” thus aligning her government with more traditional views. This stance has also led to challenges for gay couples raising children, as the administration has made it illegal for them to seek surrogacy abroad.

Since Meloni’s coalition holds a strong majority, there is a possibility that the draft law could either be rejected or modified, but it appears likely that it may ultimately pass.